Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia
Barneh, Farnaz, Koedijk, Joost B, Wijnen, Noa E, Meulendijks, Tom, Ashtiani, Minoo, Dunnebach, Ester, Dautzenberg, Noël, Cornel, Annelisa M, Krippner-Heidenreich, Anja, Klein, Kim, Zwaan, Michel C, Kuball, Jürgen, Nierkens, Stefan, Cloos, Jacqueline, Kaspers, Gertjan J L, Heidenreich, Olaf
Published in Haematologica (Roma) (08.08.2024)
Published in Haematologica (Roma) (08.08.2024)
Get full text
Journal Article
Treatment outcomes of pediatric acute myeloid leukemia in Western Kenya before and after the implementation of the SIOP PODC treatment guideline
Weelderen, Romy E., Wijnen, Noa E., Njuguna, Festus, Klein, Kim, Vik, Terry A., Olbara, Gilbert, Kaspers, Gertjan J. L.
Published in Cancer reports (01.08.2023)
Published in Cancer reports (01.08.2023)
Get full text
Journal Article
Treating CD33-Positive de novo Acute Myeloid Leukemia in Pediatric Patients: Focus on the Clinical Value of Gemtuzumab Ozogamicin
Wijnen, Noa E, Koedijk, Joost B, Klein, Kim, Luesink, Maaike, Goemans, Bianca F, Zwaan, C Michel, Kaspers, Gertjan J L
Published in OncoTargets and therapy (01.01.2023)
Published in OncoTargets and therapy (01.01.2023)
Get full text
Journal Article
Early Peripheral Blood Blast Clearance As a Prognostic Marker for Early Treatment Response in Pediatric Acute Myeloid Leukemia
Wijnen, Noa E., de Boer, Bianca, Klein, Kim, Abrahamsson, Jonas, De Moerloose, Barbara, Zeller, Bernward, Hasle, Henrik, Kovalova, Zhanna, Arad-Cohen, Nira, Kaspers, Gertjan J.L.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Chip-AML22 Master Protocol: An Open-Label Clinical Trial in Newly Diagnosed Pediatric De Novo Acute Myeloid Leukemia (AML) Patients Including a Linked Phase II Trial with Quizartinib in FLT3 -ITD/ NPM1 wt Patients - a Study By the NOPHO-DB-SHIP Consortium
Kaspers, Gertjan J.L., Wijnen, Noa E., Koedijk, Joost B., Ishimaru, Sae, Benedictus, Renske, Van Opstal, Ellen C., Van Tinteren, Harm, Zwaan, C. Michel, Biserna, Noha, Downs, Pamela, Duong, Yvonne, Kamel, Yasser Mostafa, Abrahamsson, Jonas, Arad-Cohen, Nira, Bodmer, Nicole, Castillo, Luis, Cheuk, Daniel, Costa, Vitor, De Moerloose, Barbara, Fernandez Navarro, Jose Maria, Fogelstrand, Linda, Goemans, Bianca F., Hasle, Henrik, Jonsson, Olafur G., Kovalova, Zhanna, Munthe-Kaas, Monica C., Norén-Nyström, Ulrika, Palmu, Sauli, Pasauliene, Ramune, Saks, Kadri, Tierens, Anne Maria, Turkiewicz, Dominik, Pronk, Cornelis Jan
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Chip-AML22 Master Protocol: An Open-Label Clinical Trial in Newly Diagnosed Pediatric De Novo Acute Myeloid Leukemia (AML) Patients Including a Linked Phase II Trial with Quizartinib in FLT3-ITD/ NPM1wt Patients - a Study By the NOPHO-DB-SHIP Consortium
Kaspers, Gertjan J.L., Wijnen, Noa E., Koedijk, Joost B., Ishimaru, Sae, Benedictus, Renske, Van Opstal, Ellen C., Van Tinteren, Harm, Zwaan, C. Michel, Biserna, Noha, Downs, Pamela, Duong, Yvonne, Kamel, Yasser Mostafa, Abrahamsson, Jonas, Arad-Cohen, Nira, Bodmer, Nicole, Castillo, Luis, Cheuk, Daniel, Costa, Vitor, De Moerloose, Barbara, Fernandez Navarro, Jose Maria, Fogelstrand, Linda, Goemans, Bianca F., Hasle, Henrik, Jonsson, Olafur G., Kovalova, Zhanna, Munthe-Kaas, Monica C., Norén-Nyström, Ulrika, Palmu, Sauli, Pasauliene, Ramune, Saks, Kadri, Tierens, Anne Maria, Turkiewicz, Dominik, Pronk, Cornelis Jan
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article